Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Randomized Controlled Trial of Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery

NCT04535804 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT04535804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Randomized Controlled Trial of Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2020
Completion date
September 30, 2022
Enrollment
550 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenomyosis of uterus